| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $704.5M | +1.9% |
| Cost of Revenue | $503.0M | +2.0% |
| Gross Profit | $201.5M | +1.8% |
| R&D Expense | $6.8M | -12.6% |
| SG&A Expense | $83.9M | +5.9% |
| Operating Income | $98.1M | +1.5% |
| Pre-tax Income | -$5.0M | -106.1% |
| Income Tax | $1.6M | -84.9% |
| Net Income | -$6.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $146.0M | +65.2% |
| Accounts Receivable | $77.9M | -4.2% |
| Inventory | $57.1M | +26.6% |
| Current Assets | $303.7M | +23.5% |
| Total Assets | $1.80B | -1.9% |
| Current Liabilities | $115.1M | -3.3% |
| Long-term Debt | $860.8M | -0.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $149.9M | +8.9% |
| Capital Expenditures | $69.0M | +5.5% |
| Investing Cash Flow | -$73.5M | -12.4% |
| Financing Cash Flow | -$17.8M | +80.9% |
| Free Cash Flow | $80.9M | +12.0% |
| -109.3% |
| EPS (Basic) | -$0.06 | -110.0% |
| EPS (Diluted) | -$0.06 | -110.0% |
| Total Liabilities |
| $1.10B |
| -2.7% |
| Stockholders' Equity | $700.5M | -0.7% |